BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1115 related articles for article (PubMed ID: 30611442)

  • 1. Mechanisms of Disease: Inflammatory Bowel Diseases.
    Ramos GP; Papadakis KA
    Mayo Clin Proc; 2019 Jan; 94(1):155-165. PubMed ID: 30611442
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monogenic diseases associated with intestinal inflammation: implications for the understanding of inflammatory bowel disease.
    Uhlig HH
    Gut; 2013 Dec; 62(12):1795-805. PubMed ID: 24203055
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determinants of IBD Heritability: Genes, Bugs, and More.
    Turpin W; Goethel A; Bedrani L; Croitoru Mdcm K
    Inflamm Bowel Dis; 2018 May; 24(6):1133-1148. PubMed ID: 29701818
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunopathophysiology of inflammatory bowel disease: how genetics link barrier dysfunction and innate immunity to inflammation.
    Mehta M; Ahmed S; Dryden G
    Innate Immun; 2017 Aug; 23(6):497-505. PubMed ID: 28770665
    [TBL] [Abstract][Full Text] [Related]  

  • 5. News from the "5th International Meeting on Inflammatory Bowel Diseases" CAPRI 2010.
    Latella G; Fiocchi C; Caprili R
    J Crohns Colitis; 2010 Dec; 4(6):690-702. PubMed ID: 21122584
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dismicrobism in inflammatory bowel disease and colorectal cancer: changes in response of colocytes.
    Tomasello G; Tralongo P; Damiani P; Sinagra E; Di Trapani B; Zeenny MN; Hussein IH; Jurjus A; Leone A
    World J Gastroenterol; 2014 Dec; 20(48):18121-30. PubMed ID: 25561781
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanisms of Pediatric Inflammatory Bowel Disease.
    Peloquin JM; Goel G; Villablanca EJ; Xavier RJ
    Annu Rev Immunol; 2016 May; 34():31-64. PubMed ID: 27168239
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cellular and Molecular Therapeutic Targets in Inflammatory Bowel Disease-Focusing on Intestinal Barrier Function.
    Schoultz I; Keita ÅV
    Cells; 2019 Feb; 8(2):. PubMed ID: 30813280
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Etiology and pathogenesis of inflammatory bowel disease.
    Schmidt C; Stallmach A
    Minerva Gastroenterol Dietol; 2005 Jun; 51(2):127-45. PubMed ID: 15990703
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Innate and adaptive immunity in inflammatory bowel disease.
    Geremia A; Biancheri P; Allan P; Corazza GR; Di Sabatino A
    Autoimmun Rev; 2014 Jan; 13(1):3-10. PubMed ID: 23774107
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unravelling the pathogenesis of inflammatory bowel disease.
    Xavier RJ; Podolsky DK
    Nature; 2007 Jul; 448(7152):427-34. PubMed ID: 17653185
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ocular Manifestations in Inflammatory Bowel Disease Are Associated with Other Extra-intestinal Manifestations, Gender, and Genes Implicated in Other Immune-related Traits.
    Taleban S; Li D; Targan SR; Ippoliti A; Brant SR; Cho JH; Duerr RH; Rioux JD; Silverberg MS; Vasiliauskas EA; Rotter JI; Haritunians T; Shih DQ; Dubinsky M; Melmed GY; McGovern DP
    J Crohns Colitis; 2016 Jan; 10(1):43-9. PubMed ID: 26449790
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IBD candidate genes and intestinal barrier regulation.
    McCole DF
    Inflamm Bowel Dis; 2014 Oct; 20(10):1829-49. PubMed ID: 25215613
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Th17 response and autophagy--main pathways implicated in the development of inflammatory bowel disease by genome-wide association studies.
    Díaz Peña R; Valdés E; Cofré C; Castro-Santos P
    Rev Esp Enferm Dig; 2015 Sep; 107(9):559-65. PubMed ID: 26334463
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gene-environment interactions in inflammatory bowel disease pathogenesis.
    Wang MH; Achkar JP
    Curr Opin Gastroenterol; 2015 Jul; 31(4):277-82. PubMed ID: 26039718
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The genetic background of inflammatory bowel disease: from correlation to causality.
    Uniken Venema WT; Voskuil MD; Dijkstra G; Weersma RK; Festen EA
    J Pathol; 2017 Jan; 241(2):146-158. PubMed ID: 27785786
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting the complex interactions between microbiota, host epithelial and immune cells in inflammatory bowel disease.
    Hirata Y; Ihara S; Koike K
    Pharmacol Res; 2016 Nov; 113(Pt A):574-584. PubMed ID: 27702681
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Many inflammatory bowel disease risk loci include regions that regulate gene expression in immune cells and the intestinal epithelium.
    Mokry M; Middendorp S; Wiegerinck CL; Witte M; Teunissen H; Meddens CA; Cuppen E; Clevers H; Nieuwenhuis EE
    Gastroenterology; 2014 Apr; 146(4):1040-7. PubMed ID: 24333384
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contentious host-microbiota relationship in inflammatory bowel disease--can foes become friends again?
    Satokari R
    Scand J Gastroenterol; 2015 Jan; 50(1):34-42. PubMed ID: 25523554
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multi-omics analysis of inflammatory bowel disease.
    Huang H; Vangay P; McKinlay CE; Knights D
    Immunol Lett; 2014 Dec; 162(2 Pt A):62-8. PubMed ID: 25131220
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 56.